c.ramos

TL2 Moderator · Linköping

Contributes reviews on supplier material. Based in Linköping.

Joined 5 March 2025 · last posted 1d

80 posts, newest first. Showing up to 150.

Does a peptide degrade silently, with no visual change? Replied, post #80 · Practice › Storage & stability · 27 Jul 2026 · 29 likes Coming back to post #78, because the follow-up matters more than the original answer. Beyond-use dating: the date after which a prepared solution should not be used. It…
Forced degradation studies: designing one that is informative Replied, post #107 · Analytics › Method validation · 26 Jul 2026 · 3 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
Revisiting: What pooling buys you and what it destroys Replied, post #106 · Evidence › Meta-analyses · 26 Jul 2026 · 0 likes Picking up post #103: that is the part I would want checked first. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study…
What a certificate commits its issuer to Replied, post #60 · Analytics › COA interpretation · 19 Jul 2026 · 0 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #67 · Nutrition & Training › Protein & intake · 15 Jul 2026 · 9 likes I read post #65 twice before replying, because I had assumed the opposite. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #79 · Sourcing › Independent verification · 10 Jul 2026 · 0 likes I read post #77 twice before replying, because I had assumed the opposite. Medutest: combined purity and identity reporting. Appears throughout vendor documentation.…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #64 · Compounds › Secretagogues & GH axis · 6 Jul 2026 · 0 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #43 · Pharmacology › Pharmacokinetics · 6 Jul 2026 · 2 likes Worth separating two things that post #39 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Revisiting: What pooling buys you and what it destroys Replied, post #47 · Evidence › Meta-analyses · 8 Jun 2026 · 11 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #11 · Practice › Side effects · 28 May 2026 · 0 likes post #10 is right about the mechanism and I think understates the practical bit. Constipation: common, manageable, and frequently under-reported because it is not…
Area percent versus weight percent: the confusion that causes most arguments Replied, post #12 · Analytics › HPLC & UHPLC · 26 May 2026 · 18 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
An 18-month record including the parts that went badly Replied, post #24 · Outcomes › Progress reports · 25 May 2026 · 20 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #5 · Analytics › HPLC & UHPLC · 20 May 2026 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #25 · Practice › Dosing & titration · 17 May 2026 · 4 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
Reconstitution volumes that produce round numbers, tabulated Replied, post #100 · Practice › Reconstitution · 26 Apr 2026 · 2 likes Coming back to post #98, because the follow-up matters more than the original answer. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
Type 2 diabetes and the largest part of the evidence base Replied, post #80 · Clinical › Comorbidities · 23 Apr 2026 · 7 likes post #79 is right about the mechanism and I think understates the practical bit. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea…
A plateau that disappeared when I changed how I measured — the long version Replied, post #27 · Outcomes › Progress reports · 15 Apr 2026 · 12 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #48 · Practice › Administration · 7 Apr 2026 · 0 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
Transporting a vial for a weekend away — a second dataset Replied, post #20 · Practice › Storage & stability · 4 Apr 2026 · 15 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
Gastro-oesophageal reflux: improving or worsening? Replied, post #27 · Clinical › Comorbidities · 16 Mar 2026 · 32 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #46 · Lounge › Introductions · 12 Mar 2026 · 0 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
The most common factual error about semaglutide on the internet — what changed since Replied, post #38 · Compounds › Semaglutide · 1 Mar 2026 · 5 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #25 · Practice › Administration · 28 Feb 2026 · 14 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
Why the titration planner refuses to produce a schedule below a floor Replied, post #41 · Data & Tools › Calculators · 20 Feb 2026 · 23 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #33 · Compounds › Semaglutide · 17 Feb 2026 · 0 likes On post #29 — agreed on the reasoning, with one qualification. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the…
Anaesthesia and elective surgery: the aspiration question Replied, post #18 · Practice › Interactions · 10 Feb 2026 · 11 likes post #17 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Trifluoroacetate content and its consequences Replied, post #56 · Analytics › Impurities & related substances · 31 Jan 2026 · 0 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #40 · Evidence › Trials · 28 Jan 2026 · 11 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #34 · Research Methods › N-of-1 designs · 7 Jan 2026 · 31 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
Prescription requirements and telehealth models Replied, post #94 · Sourcing › Regulatory · 27 Dec 2025 · 0 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #40 · Access › Pricing · 18 Dec 2025 · 15 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
Pen dose counters: what a click does and does not guarantee Replied, post #89 · Devices › Pens & autoinjectors · 18 Nov 2025 · 7 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
Availability by country, dated, with primary sources Replied, post #38 · Access › International · 29 Oct 2025 · 27 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
Request: a diff view for wiki revisions — the long version Replied, post #60 · Meta › Feature requests · 24 Oct 2025 · 0 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.
Reading SURMOUNT-1 without the press release Replied, post #42 · Compounds › Tirzepatide · 23 Oct 2025 · 22 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Started this topic · Sourcing › Regulatory · 22 Oct 2025 · 7 likes Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #21 · Start Here › Welcome · 13 Oct 2025 · 2 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #43 · Compounds › Tirzepatide · 12 Oct 2025 · 16 likes post #42 answers the question as asked. The question underneath it is different. Titration schedules for tirzepatide have more dose steps than semaglutide partly…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #68 · Evidence › Study critique · 14 Sep 2025 · 2 likes This follows post #65 rather than contradicting it. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #103 · Compounds › Retatrutide · 30 Aug 2025 · 12 likes Coming back to post #101, because the follow-up matters more than the original answer. Mass and identity: a report on retatrutide should state the mass detected by…
A parcel that arrived warm: a decision process, not a verdict Replied, post #10 · Practice › Storage & stability · 23 Aug 2025 · 9 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #96 · Clinical › Comorbidities · 19 Aug 2025 · 10 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
Hepatic impairment and the absence of data Replied, post #15 · Clinical › Special populations · 18 Aug 2025 · 9 likes This follows post #12 rather than contradicting it. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait…
Documentation that appears only after payment Replied, post #7 · Sourcing › Red flags · 18 Aug 2025 · 26 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
A ten-fold dose error caught before injection — one year on Replied, post #136 · Devices › Syringes & needles · 5 Aug 2025 · 20 likes Coming back to post #134, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Validating a method you did not develop Started this topic · Analytics › Method validation · 1 Aug 2025 · 5 likes On the subject in the title: Validating a method you did not develop Working notes rather than a conclusion. I would like to understand what this number means before I…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #24 · Evidence › Journal club · 27 Jul 2025 · 4 likes Worth separating two things that post #20 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Counter-ion content and its effect on measured mass Replied, post #103 · Analytics › Mass spectrometry · 26 Jul 2025 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 5 Jul 2025 · 0 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
A report I filed that turned out to be wrong, and the correction Replied, post #121 · Sourcing › Vendor reports · 25 Jun 2025 · 0 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
[2026 update] Splitting an overlong document into two Replied, post #11 · Documentation › Wiki requests · 20 Jun 2025 · 7 likes Picking up post #8: that is the part I would want checked first. Authority and authorship: if you think a maintained page needs input from someone with specific…
Revisiting: What to include when your question involves arithmetic Replied, post #2 · Start Here › How to Ask · 17 Jun 2025 · 14 likes This follows the opening post rather than contradicting it. What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells…
Reading an MS report that only gives you a single number Replied, post #109 · Analytics › Mass spectrometry · 16 Jun 2025 · 2 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
Reading a trial's population section before its results — does this still hold? Replied, post #127 · Evidence › Trials · 21 May 2025 · 10 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Telehealth prescribing models in the US Replied, post #97 · Regional › North America · 11 May 2025 · 0 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #26 · Sourcing › Independent verification · 25 Apr 2025 · 14 likes Picking up post #23: that is the part I would want checked first. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #58 · Compounds › Secretagogues & GH axis · 12 Apr 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Validating a calculator against hand arithmetic — what changed since Started this topic · Data & Tools › Calculators · 1 Apr 2025 · 1 like Posting this under the heading it deserves: Validating a calculator against hand arithmetic — what changed since Everything below is what sits behind that. Working…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #110 · Sourcing › Vendor reports · 18 Mar 2025 · 2 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #8 · Devices › Cold chain · 13 Mar 2025 · 14 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #53 · Evidence › Journal club · 8 Mar 2025 · 5 likes post #52 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #113 · Data & Tools › Calculators · 3 Mar 2025 · 0 likes Coming back to post #111, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
What we do not know about retatrutide, listed explicitly Replied, post #114 · Compounds › Retatrutide · 27 Feb 2025 · 17 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #30 · Evidence › Meta-analyses · 7 Feb 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Research-use-only status: what it means legally and practically — a second dataset Replied, post #81 · Compounds › Other compounds · 4 Feb 2025 · 4 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
Journal club: SURMOUNT-1, read without the press release Replied, post #48 · Evidence › Journal club · 23 Jan 2025 · 1 like post #47 answers the question as asked. The question underneath it is different. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #137 · Compounds › Tirzepatide · 8 Jan 2025 · 8 likes Coming back to post #135, because the follow-up matters more than the original answer. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #20 · Compounds › Semaglutide · 8 Jan 2025 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Converting between mg/mL and units per dose, both directions Replied, post #142 · Practice › Reconstitution · 23 Dec 2024 · 8 likes post #141 is right about the mechanism and I think understates the practical bit. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
Body image changing more slowly than the body Replied, post #77 · Wellbeing › Mental health · 19 Dec 2024 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Persistent vomiting and the threshold for seeking help — one year on Replied, post #8 · Safety › Adverse events · 18 Dec 2024 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #149 · Analytics › COA interpretation · 12 Dec 2024 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
SURPASS-2 and the comparator dose question that will not go away Replied, post #75 · Compounds › Tirzepatide · 9 Dec 2024 · 31 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #21 · Clinical › Special populations · 21 Nov 2024 · 6 likes Coming back to post #19, because the follow-up matters more than the original answer. Adolescents: a distinct evidence base exists. The compounds are not approved for…
EMA product information as a primary source — does this still hold? Replied, post #77 · Regional › European Union · 17 Nov 2024 · 8 likes Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict weight-management coverage. Others are more permissive. That variation…
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #9 · Compounds › Tirzepatide · 15 Nov 2024 · 5 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
Time to steady state after a dose increase Replied, post #107 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 14 likes On post #103 — agreed on the reasoning, with one qualification. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #54 · Clinical › Comorbidities · 18 Oct 2024 · 0 likes post #53 answers the question as asked. The question underneath it is different. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea…
Reporting a discrepancy without making an allegation Replied, post #73 · Sourcing › Vendor reports · 14 Sep 2024 · 7 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
Guidelines revision: what changed and why Replied, post #143 · Meta › Announcements · 29 Jul 2024 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…